Rankings
▼
Calendar
IOBT Q2 2020 Earnings — IO Biotech, Inc. Revenue & Financial Results | Market Cap Arena
IOBT
IO Biotech, Inc.
$18M
Q2 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$2M
Net Income
-$3M
EPS (Diluted)
$-19.81
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$2,350
Free Cash Flow
-$2,350
Stock-Based Comp.
$16
← FY 2020
All Quarters
Q3 2020 →
